##  [5 Key Benefits of Literature Based Submissions for Generic Drugs](/white-papers/5-key-benefits-of-literature-based-submissions-for-generic-drugs) 

- [Medicinal Products](/white-papers-categories/medicinal-products)
- [Medical Writing](/white-papers-categories/medical-writing)





 ![5 Key Benefits of Literature Based Submissions for Generic Drugs]()

The generic drug market is a cornerstone of global healthcare, delivering affordable alternatives that reduce costs and expand access. Yet bringing generics to market poses significant Regulatory and scientific challenges-particularly demonstrating safety, efficacy, and quality without duplicative trials. Literature-Based Submissions (LBS) offer a smart, efficient bridge, leveraging existing high-quality evidence to support applications for generic molecules with modified formulations or usage profiles.

This whitepaper explores five pivotal benefits of using LBS for generic drug development and submission. As a global provider of Regulatory medical writing services, we help life sciences and pharma clients seamlessly employ LBS-accelerating market entry, reducing costs, and enhancing credibility through skilled evidence synthesis.



Fill the form below to download the White Paper

 You must have JavaScript enabled to use this form.

  

  

  

 How did you hear about us?Search EngineE-mail CampaignGoogle AdsSocial MediaLink from another websiteColleague’s RecommendationNewsletterPrinted BrochureOther 

  

 

 

     I have read the [privacy policy](https://www.freyrsolutions.com/privacy-policy) 



 

 Submitted Page URL  

 Website URL  

 Content Type  

 Form Name